InSilico jumps on collaboration to develop biological frontier foundation models

Insilico Medicine Cayman TopCo

21/09/2026 07:01

** Shares of InSilico Medicine Cayman TopCo 3696.HK jump 7.2% to HK$65.2, the highest level since May 12
** Stock of AI-driven drug discovery and pipeline development group on track for third straight session of gains
** InSilico enters into collaboration with a frontier foundation model lab, with contract value of tens of millions of U.S. dollars, to co-develop, validate, commercialize a series of frontier foundation models engineered for biological research
** The collaboration will build specific foundation models for generative biology and the parties have established a revenue-sharing framework to drive global commercialization across their respective biopharmaceutical partner networks - co
** YTD, stock up 72.9%, Hang Seng Biotech Index .HSBIO up 15.9%


 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))